Aspen Pharmacare 

$9.92
39
+$0.09+0.92% 19:35 Today

Statistics

Day High
10.04
Day Low
10.04
52W High
10.11
52W Low
5.25
Volume
100
Avg. Volume
589
Mkt Cap
4.43B
P/E Ratio
-
Dividend Yield
1.42%
Dividend
0.14

Upcoming

Dividends

1.42%Dividend Yield
Nov 2026
$0.14
Oct 2025
$0.12
Oct 2024
$0.21
Oct 2023
$0.18
Oct 2022
$0.18
10Y Growth
-2.12%
5Y Growth
-4.15%
3Y Growth
-7.86%
1Y Growth
15.13%

Earnings

Sep 2Expected
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.18
0.37
0.55
Expected EPS
N/A
Actual EPS
N/A

Financials

6.28%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.57BRevenue
161.17MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APNHY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company that competes with Aspen in various therapeutic areas, including anti-infectives and cardiovascular drugs.
Novartis
NVS
Mkt Cap303.67B
Novartis is a multinational pharmaceutical company that competes across several of the same therapeutic areas as Aspen, including generic medicines through its Sandoz division.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that compete with Aspen's portfolio, including in the areas of women's health and general medicines.
Merck
MRK
Mkt Cap368.89B
Merck is a global healthcare company that competes with Aspen, particularly in the areas of infectious diseases and cardiovascular health.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with Aspen in the development and marketing of pharmaceuticals and vaccines, including in respiratory diseases and HIV.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Aspen in the pharmaceutical sector, particularly in the areas of immunology and oncology, areas Aspen is expanding into.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with Aspen, offering a broad portfolio of drugs that overlap with Aspen's, including in the areas of cardiovascular diseases and central nervous system disorders.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.09B
Teva Pharmaceutical Industries is a leading generic pharmaceutical company that competes with Aspen's manufacturing and distribution of generic medicines.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with Aspen in several therapeutic areas, including respiratory, cardiovascular, and metabolic diseases, areas where Aspen also operates.

About

Aspen Pharmacare Holdings Limited is a global pharmaceutical entity that develops, manufactures, and distributes a wide array of specialized and branded medicinal products. The company operates through two primary segments: Commercial Pharmaceuticals and Manufacturing. Its diverse product portfolio encompasses essential anesthetic agents, such as general anesthetics, muscle relaxants, and topical preparations. Aspen also provides a comprehensive suite of thrombosis treatments, including various injectable anticoagulants like low molecular weight heparins, Xa inhibitors, and other heparin derivatives. Beyond these, the firm markets numerous regional consumer, prescription, and over-the-counter brands, such as Circadin for sleep, Foxair for respiratory ailments, Maltofer as an iron supplement, Mybulen for pain management, and Zyloric for gout. Additionally, Aspen produces active pharmaceutical ingredients and finished dose form products for other companies. Established in 1850, the company's headquarters are located in Durban, South Africa.
Show More
CEO
Stephen Bradley Saad
Employees
7454
Country
South Africa
ISIN
US04530Y1064
WKN
000A2PWTE

Listings

0 Comments

Share your thoughts

FAQs

What is Aspen Pharmacare stock price today?▼
The current price of APNHY is $9.92 USD — it has increased by +0.92% in the past 24 hours. Watch Aspen Pharmacare stock price performance more closely on the chart.
What is Aspen Pharmacare stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Aspen Pharmacare stocks are traded under the ticker APNHY.
Is Aspen Pharmacare stock price growing?▼
APNHY stock has risen by +1.54% compared to the previous week, the month change is a +4.2% rise, over the last year Aspen Pharmacare has showed a +79.71% increase.
What is Aspen Pharmacare market cap?▼
Today Aspen Pharmacare has the market capitalization of 4.43B
When is the next Aspen Pharmacare earnings date?▼
Aspen Pharmacare is going to release the next earnings report on March 11, 2027.
What is Aspen Pharmacare revenue for the last year?▼
Aspen Pharmacare revenue for the last year amounts to 2.57B USD.
What is Aspen Pharmacare net income for the last year?▼
APNHY net income for the last year is 161.17M USD.
Does Aspen Pharmacare pay dividends?▼
Yes, APNHY dividends are paid annual. The last dividend per share was 0.14 . As of today, Dividend Yield (FWD)% is 1.42%.
How many employees does Aspen Pharmacare have?▼
As of November 6, 2026, the company has 7,454 employees.
In which sector is Aspen Pharmacare located?▼
Aspen Pharmacare operates in the Health & Wellness sector.
When did Aspen Pharmacare complete a stock split?▼
The last stock split for Aspen Pharmacare was on July 18, 2012 with a ratio of 5:1.
Where is Aspen Pharmacare headquartered?▼
Aspen Pharmacare is headquartered in Durban, South Africa.